As of September 11, 2026, Cemex S.A.B. de C.V. Sponsored (CX) trades at $10.67. CleaRank Financial AI rates it Buy with a fair value of $14.70, 37.8% above the current price. Wall Street's consensus target is $14.70 across 15 analysts. RSI at 36 is in neutral territory, and the price is below its 50-day average of $11.59.
Cemex S.A.B. de C.V. Sponsored (CX)
Cemex S.A.B. de C.V. Sponsored NYSE
CX Price Analysis
Market Metrics
Peer Benchmarking
Valuation vs Sector (Basic Materials)
Performance vs XLB
Sector Position Analysis
CX Financial Performance
Revenue vs. Earnings
Annual
Quarterly
CX Analysis
- Monitor Cemex's ability to reclaim its 50-day and 200-day moving averages for signs of a technical trend reversal.
- Given the moderate insider selling signal, keep an eye on any further transactions that could indicate management's confidence level.
- As a building materials company, Cemex's performance is closely tied to macroeconomic conditions and construction spending; stay informed on sector-specific economic data.
15 analysts maintain a 'Strong Buy' or 'Buy' rating, with a median price target of $14.70, indicating significant upside potential.
Source: Wall Street AnalystsCurrent year revenue is estimated to grow by 8.00% to $17.4 billion, with continued growth expected next year, supporting fundamental strength.
Source: Wall Street Revenue EstimatesThe stock is trading below its 50-day and 200-day moving averages ($11.59 and $11.90), and the RSI is in bearish territory, suggesting potential for further price declines.
Source: Technical AnalysisInsiders have sold $425,600 worth of stock across 9 transactions with no reported purchases, indicating a moderate insider selling.
Source: Insider TransactionsKey Statistics
| Market Cap | 464.19B |
|---|---|
| P/E Ratio | 31.03 |
| EPS (TTM) | 0.3500 |
| Dividend Yield | 0.00% |
| 52 Week High | 13.67 |
| 52 Week Low | 8.73 |
Earnings & Growth Analysis
Key Risks
Technical Indicators
| RSI (14) | 36.22 |
|---|---|
| MACD | -0.22 |
| SMA 50 | 11.59 |
| SMA 200 | 11.90 |
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
CX Trade Plans
Specific entry, exit, and risk management levels
🟢 LONG ENTRY (click to switch)
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
A $10,000 investment in CX in September 2016 would be worth about $13,806 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CX today could grow to about $16,382 by 2036 in the base case, with a bull case near $93,443 and a bear case around $2,872. Projections are statistical simulations, not guarantees.
CX Stock Price Prediction: 2030
CleaRank's simulation projects a price near $12.99 for CX by 2030 in the base case, from $10.67 today (1.2x over 4 years). The downside path ends near $4.32. These are outcomes of a Monte Carlo simulation run on CX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $6.46 | $11.20 | $19.43 |
| 2028 | $5.40 | $11.77 | $25.65 |
| 2029 | $4.77 | $12.37 | $32.10 |
| 2030 | $4.32 | $12.99 | $39.08 |
| 2031 | $3.99 | $13.65 | $46.76 |
| 2032 | $3.72 | $14.34 | $55.25 |
| 2033 | $3.51 | $15.07 | $64.67 |
| 2034 | $3.34 | $15.83 | $75.13 |
| 2035 | $3.19 | $16.63 | $86.75 |
| 2036 | $3.06 | $17.47 | $99.66 |
Method: 10,000 simulated price paths using CX's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CX Insider Trading Analysis
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 28, 2026 | GONZALEZ HERRERA JESUS VICENTE
Officer
|
Sell | 35.0K | $425.6K |
| Jul 1, 2026 | MARTINEZ MERLA JAIME
Officer
|
Grant | 7.7K | - |
| Jun 15, 2026 | ECHAVEZ HERNANDEZ LUIS
Officer
|
Grant | 81.7K | - |
| Jun 15, 2026 | RAMIREZ CANTU ALEJANDRO ALBERTO
Officer
|
Grant | 30.5K | - |
| Jun 12, 2026 | GONZALEZ FLORES JOSE ANTONIO
Officer
|
Grant | 75.5K | - |
| May 1, 2026 | DOEHNER COBIAN MAURICIO
Officer
|
Grant | 38.3K | - |
| May 1, 2026 | MUGUIRO DOMINGUEZ JAIME
Chief Executive Officer
|
Grant | 333.6K | - |
| May 1, 2026 | SALDANA MADERO ROGER
Officer
|
Grant | 37.1K | - |
| May 1, 2026 | ZAMBRANO LOZANO ROGELIO
Director
|
Grant | 205.6K | - |
